Related Experiment Video
Updated: Jun 23, 2026
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
EGFR mutation up-regulates EGR1 expression through the ERK pathway
Mari Maegawa1, Tokuzo Arao, Hideyuki Yokote
1Department of Genome Biology, Kinki University School of Medicine, Osaka 589-8511, Japan.
Anticancer Research
|May 6, 2009
Summary
Mutant EGFR signaling up-regulates Early Growth Response 1 (EGR1) via the ERK pathway. This finding reveals a key target gene of mutant EGFR, enhancing understanding of its oncogenic properties.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Epidermal Growth Factor Receptor (EGFR) mutations, specifically DelE746_A750, lead to constitutive activation of EGFR signaling.
- The downstream gene expression changes in cells harboring mutant EGFR are not fully understood.
Purpose of the Study:
- To investigate the gene expression profile of cells with mutant EGFR.
- To identify specific genes regulated by constitutively active EGFR.
Main Methods:
- Gene expression analysis was performed on HEK293 cells transfected with wild-type or mutant EGFR.
- Quantitative RT-PCR and immunoblotting were used to confirm gene expression levels.
- Pharmacological inhibitors (U0126, LY294002) were used to probe signaling pathways.
Main Results:
- Early Growth Response 1 (EGR1) was the most significantly upregulated gene in mutant EGFR-transfected cells.
- EGR1 expression increased with EGF stimulation and decreased with EGFR-tyrosine kinase inhibitor treatment.
- MEK inhibitor U0126 suppressed EGR1 expression, while a PI3K inhibitor did not.
Conclusions:
- Mutant EGFR constitutively upregulates EGR1 expression through the ERK signaling pathway.
- EGR1 expression levels correlate with EGFR signal activation.
- This study identifies EGR1 as a target gene of mutant EGFR, contributing to understanding its oncogenic potential.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...